PTC Therapeutics Inc (NASDAQ:PTCT) shares, rose in value on Friday, March 28, with the stock price down by -1.36% to the previous day’s close as strong demand from buyers drove the stock to $54.24.
Actively observing the price movement in the last trading, the stock closed the session at $54.99, falling within a range of $53.53 and $55.285. The value of beta (5-year monthly) was 0.66. Referring to stock’s 52-week performance, its high was $58.38, and the low was $24.00. On the whole, PTCT has fluctuated by 7.26% over the past month.
With the market capitalization of PTC Therapeutics Inc currently standing at about $4.28 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 950.89M, with a low estimate of 149.2M and a high estimate of 1.18B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 437.16M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PTCT’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of PTCT currently trading nearly -0.40% and 6.64% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.32, while the 7-day volatility ratio is showing 2.94% which for the 30-day chart, stands at 5.09%. Furthermore, PTC Therapeutics Inc (PTCT)’s beta value is 0.54, and its average true range (ATR) is 2.19.
A comparison of PTC Therapeutics Inc (PTCT) with its peers suggests the former has fared considerably weaker in the market. PTCT showed an intraday change of -1.36% in last session, and over the past year, it grew by 93.99%%.
Data on historical trading for PTC Therapeutics Inc (NASDAQ:PTCT) indicates that the trading volumes over the past 10 days have averaged 0.74 and over the past 3 months, they’ve averaged 748.21K. According to company’s latest data on outstanding shares, there are 77.70 million shares outstanding.
Nearly 2.60% of PTC Therapeutics Inc’s shares belong to company insiders and institutional investors own 97.64% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.3 million shares as on 2025-03-14, resulting in a short ratio of 5.08. According to the data, the short interest in PTC Therapeutics Inc (PTCT) stood at 838.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.7 million. The stock has risen by 20.16% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PTCT stock heading into the next quarter.
